Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα

Abstract

There are two IL-15 isoforms and eight isoforms for the IL-15Rα chain whose biological role is poorly understood. Here, we have analysed the intracellular trafficking of IL-15 and IL-15Rα and tried to shed some light on their function(s). In IL-15/GFP CHO transfectants both IL-15 isoforms show nuclear localization. Two melanoma cell lines (MELP and MELREO) spontaneously expressing the IL-15 isoforms, display different intracellular trafficking of the IL-15/IL-15Rα complex. In MELP cells only IL-15Rα is detected inside the nucleus, whereas IL-15 and IL-15Rα assemble at the cell surface and are internalized. Moreover, the transducing molecule TRAF2 co-immunoprecipitates with IL-15Rα and may be deflected to TNFRI using anti-IL-15 blocking mAbs and TNF-α. By contrast, MELREO cells display IL-15Rα and IL-15 nuclear localization but only a partial co-localization of these molecules on the cell surface. In these cells, TRAF2 is strongly associated with IL-15Rα and cannot be deflected by any treatment. Since TRAF2 activates the transcription factor NF-κB, IL-15 through IL-15Rα, could have a role in the control of this pathway. Indeed, anti-IL-15 MaB inhibit the constitutive nuclear localization of NFκB and the phosphorylation of its inhibitor Iκ-Bα. Thus, IL-15Rα controls NF-κB activation, however differences in the intracellular trafficking of the IL-15 and/or IL-15Rα suggest a different biological role for this complex in MELP versus MELREO cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alleva DG, Kaser SB, Monroy MA, Fenton MJ and Beller DI. . 1997 J. Immunol. 159: 2941–2951.

  • Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NJ, Valentine V, Shapiro DN, Park LS and Cosman D. . 1995 J. Biol. Chem. 270: 29862–29869.

  • Baldwin Jr AS. . 1996 Annu. Rev. Immunol. 14: 649–681.

  • Baker SJ and Reddy EP. . 1996 Oncogene 12: 1–9.

  • Bamford RN, Battiata AP, Burton JD, Sharma H and Waldmann TA. . 1996 Proc. Natl. Acad. Sci. USA 93: 2897–2902.

  • Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S and Azzarone B. . 1998 Oncogene 16: 2503–2512.

  • Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R and Krause H. . 1999 FASEB J. 12: 1575–1585.

  • Dubois S, Magrangeas F, Lehours P, Raher S, Bernard J, Boisteau O, Leroy S, Minvielle S, Godard A and Jacques Y. . 1999 J. Biol. Chem. 38: 26978.

  • Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U and Van Waes C. . 1999 Cancer Res. 59: 3468–3474.

  • Gaggero A, Azzarone B, Andrei C, Mishal Z, Meazza R, Zappia E, Rubartelli A and Ferrini S. . 1999 Eur. J. Immunol. 4: 1265.

  • Ghosh S, May MJ and Kopp EB. . 1998 Annu. Rev. Immunol. 16: 225–260.

  • Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D and Anderson D. . 1994 EMBO J. 13: 2822–2830.

  • Hallahan DE, Virudachalam S, and Kuchibhotla J. . 1998 Cancer Res. 58: 5484–5488.

  • Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B and Ferrini S. . 1997 Eur. J. Immunol. 27:: 1049–1054.

  • Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo AM, Colombo MP, Azzarone B and Ferrini S. . 1996 Oncogene 12: 2187–2192.

  • Musso T, Calosso L, Zucca M, Millesimo M, Ravarino D, Giovarelli M, Malavasi F, Ponzi AN, Paus R and Bulfone-Paus S. . 1999 Blood 10: 3531.

  • Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, Matsuguchi T, Suzuki M, Ohashi PS and Yoshikai Y. . 2000 J. Exp. Med. 191: 157.

  • Shah MH, Hackshaw KV and Caligiuri MA. . 1998 Nat. Med. 4: 643.

  • Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN and Waldmann TA. . 1997 Proc. Natl. Acad. Sci. USA 94: 14444–14449.

  • Waldmann TA and Tagaya Y. . 1999 Annu. Rev. Immunol. 17: 19–48.

  • Washizu J, Nishimura H, Nakamura N, Nimura Y and Yoshikai Y. . 1998 Immunogenetics 48: 1–7.

Download references

Acknowledgements

This work was supported by grants from ARC, ANRB (Villejuif, France), AIRC, and MURST. A Gaggero is a recipient of a FIRC fellowship. J Giron-Michel and E Cazes are recipients of an A.R.M.I.A. fellowship.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pereno, R., Giron-Michel, J., Gaggero, A. et al. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19, 5153–5162 (2000). https://doi.org/10.1038/sj.onc.1203873

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203873

Keywords

This article is cited by

Search

Quick links